{"id":"NCT01432236","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","briefTitle":"A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression","officialTitle":"A Phase 3b Multicenter, Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study Of Pregabalin In The Treatment Of Fibromyalgia With Concurrent Antidepressant Therapy For Comorbid Depression (Protocol A0081275)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2013-07","completion":"2013-07","firstPosted":"2011-09-12","resultsPosted":"2014-10-22","lastUpdate":"2021-01-22"},"enrollment":197,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Fibromyalgia"],"interventions":[{"type":"DRUG","name":"Pregabalin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Pregabalin","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The intent of this study is to identify and treat fibromyalgia subjects with comorbid depression who are receiving an SSRI (selective serotonin reuptake inhibitor) or SNRI (selective norepinephrine reuptake inhibitor) primarily for their depression and to determine whether pregabalin demonstrates improvement relative to placebo in improving pain associated with fibromyalgia.","primaryOutcome":{"measure":"Mean NRS Pain Score at End of Period.","timeFrame":"End of each period, at Weeks 6 and 14","effectByArm":[{"arm":"Pregabalin","deltaMin":4.84,"sd":0.15},{"arm":"Placebo","deltaMin":5.45,"sd":0.16}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":37,"countries":["United States","Canada","Italy","Spain"]},"refs":{"pmids":["27057659","26034150"],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0081275&StudyName=A%20Phase%203b%20Multicenter%20Study%20of%20Pregabalin%20in%20Fibromyalgia%20Subjects%20Who%20Have%20Comorbid%20Depression"]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":181},"commonTop":["Dizziness","Somnolence","Headache","Nausea","Constipation"]}}